scispace - formally typeset
Open AccessJournal Article

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

Shaul G. Massry, +80 more
- 01 Oct 2003 - 
- Vol. 42
Reads0
Chats0
About
This article is published in American Journal of Kidney Diseases.The article was published on 2003-10-01 and is currently open access. It has received 2609 citations till now. The article focuses on the topics: Chronic kidney disease-mineral and bone disorder & Kidney disease.

read more

Citations
More filters
Journal ArticleDOI

Vegetarian Compared with Meat Dietary Protein Source and Phosphorus Homeostasis in Chronic Kidney Disease

TL;DR: Dietary counseling of patients with CKD must include information on not only the amount of phosphate but also the source of protein from which the phosphate derives, as demonstrated by a crossover trial in nine patients with advanced chronic kidney disease.
Journal Article

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Commentary

TL;DR: In this paper, the authors compared sevelamer and calcium-based binders on all-cause and cause-specific mortality (cardiovascular, infection, and other) in prevalent hemodialysis patients.
Journal ArticleDOI

Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease

TL;DR: In this paper, the absolute dietary phosphorus (P) content as well as the P-to-protein ratio in foods should be addressed during dietary counseling of patients with chronic kidney disease during hemodialysis treatment sessions in the dialysis clinic.
Journal ArticleDOI

Vitamin D levels and patient outcome in chronic kidney disease.

TL;DR: It is shown that plasma 25-hydroxyvitamin D is an independent inverse predictor of disease progression and death in patients with stage 2-5 chronic kidney disease.
Journal ArticleDOI

Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis: A Randomized, Double-Blind, Multicenter Study

TL;DR: Once-daily oral cinacalcet was effective in rapidly and safely reducing PTH, Ca x P, calcium, and phosphorus levels in patients who received HD or PD and significantly reduced serum calcium, phosphorus, and Ca X P levels compared with control treatment.
References
Related Papers (5)